The serine protease plasmin plays detrimental roles in epithelial sodium channel activation and podocyte injury in Dahl salt-sensitive rats
Open Access
- 15 October 2022
- journal article
- research article
- Published by Springer Nature in Hypertension Research
- Vol. 46 (1) , 50-62
Abstract
Salt-sensitive hypertension is associated with poor clinical outcomes. The epithelial sodium channel (ENaC) in the kidney plays pivotal roles in sodium reabsorption and blood pressure regulation, in which its γ subunit is activated by extracellular serine proteases. In proteinuric nephropathies, plasmin filtered through injured glomeruli reportedly activates γENaC in the distal nephron and causes podocyte injury. We previously reported that Dahl salt-sensitive (DS) rats fed a high-salt (HS) diet developed hypertension and proteinuria along with γENaC activation and that a synthetic serine protease inhibitor, camostat mesilate, mitigated these changes. However, the role of plasmin in DS rats remained unclear. In this study, we evaluated the relationship between plasmin and hypertension as well as podocyte injury and the effects of plasmin inhibitors in DS rats. Five-week-old DS rats were divided into normal-salt diet, HS diet, and HS+plasmin inhibitor (either tranexamic acid [TA] or synthetic plasmin inhibitor YO-2) groups. After blood pressure measurement and 24 h urine collection over 5 weeks, rats were sacrificed for biochemical analyses. The HS group displayed severe hypertension and proteinuria together with activation of plasmin in urine and γENaC in the kidney, which was significantly attenuated by YO-2 but not TA. YO-2 inhibited the attachment of plasmin(ogen) to podocytes and alleviated podocyte injury by inhibiting apoptosis and inflammatory/profibrotic cytokines. YO-2 also suppressed upregulation of protease-activated receptor-1 and phosphorylated ERK1/2. These results indicate an important role of plasmin in the development of salt-sensitive hypertension and related podocyte injury, suggesting plasmin inhibition as a potential therapeutic strategy.Keywords
This publication has 50 references indexed in Scilit:
- Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodiumHypertension Research, 2013
- Proteolytic activation of the epithelial sodium channel and therapeutic application of a serine protease inhibitor for the treatment of salt-sensitive hypertensionClinical and Experimental Nephrology, 2011
- Aberrant ENaC activation in Dahl salt-sensitive ratsJournal Of Hypertension, 2009
- Plasmin in Nephrotic Urine Activates the Epithelial Sodium ChannelJournal of the American Society of Nephrology, 2009
- Plasmin Activates Epithelial Na+ Channels by Cleaving the γ SubunitJournal of Biological Chemistry, 2008
- Plasmin(ogen) Promotes Renal Interstitial Fibrosis by Promoting Epithelial-to-Mesenchymal TransitionJournal of the American Society of Nephrology, 2007
- Plasmin is not protective in experimental renal interstitial fibrosis1Kidney International, 2004
- Tranexamic AcidDrugs, 2003
- Disorders of the Epithelial Na+ Channel in Liddle’s Syndrome and Autosomal Recessive Pseudohypoaldosteronism Type 1Nephron Experimental Nephrology, 2000
- Effect of proteinase inhibitor Camostat Mesilate on nephrotic syndrome with diabetic nephropathyJournal of Diabetic Complications, 1991